QQ客服 官方微博 反馈留言

	Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance tOcisplatin, taxol, and gefitinib
	Hui-ling LI[1]; Si-ming XIE[2]; Liang ZHANG[3]; Cheng-jie CAI[1]; Wei WANG[1]; Jun HUANG[1]; Dao-yuan WANG[1]; Dan-ping WEN[1]; Qiu-hua DENG[1]; Nan-shah ZHONG[1]
	2010
期号	5页码:601
关键词	肺腺癌 Am1010 multi-drug-resistance 转移 药幸存房间 焦点并且房间粘附
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4439810
专题	暨南大学
作者单位	1.[1]Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Disease, The 1st Affiliated Hospital of Guangzhou Medical College, Guangzhou 510120, China 2.[2]pathology Department, Jinan University, Guangzhou 510100, China 3.[3]SNational Engineering Research Center for Beijing Biochip Technology, 18 Life Science Parkway, Changping District, Beijing 102206, China
推荐引用方式 GB/T 7714	Hui-ling LI[1],Si-ming XIE[2],Liang ZHANG[3],et al. Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance tOcisplatin, taxol, and gefitinib[J],2010(5):601.
APA	Hui-ling LI[1].,Si-ming XIE[2].,Liang ZHANG[3].,Cheng-jie CAI[1].,Wei WANG[1].,...&Jian-xing HE[1].(2010).Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance tOcisplatin, taxol, and gefitinib.(5),601.
MLA	Hui-ling LI[1],et al."Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance tOcisplatin, taxol, and gefitinib"..5(2010):601.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。